Candriam Equities L Biotech.R-H CHF Acc/ LU1269736754 /
| NAV22/01/2025 | Diferencia+0.4300 | Tipo de beneficio | Enfoque de la inversión | Sociedad de fondos |
|---|---|---|---|---|
| 199.6900CHF | +0.22% | reinvestment | Equity Worldwide | Candriam ▶ |
| NAV22/01/2025 | Diferencia+0.4300 | Tipo de beneficio | Enfoque de la inversión | Sociedad de fondos |
|---|---|---|---|---|
| 199.6900CHF | +0.22% | reinvestment | Equity Worldwide | Candriam ▶ |